Connect with us

Company News

Novo Integrated Sciences closes on $6,210,000 securities purchase agreement

Novo Integrated Sciences, Inc. announced the Company has entered into a securities purchase agreement, dated April 5, 2024, with Streeterville Capital, LLC (“Streeterville”) pursuant to which the Company issued a secured convertible promissory note with a maturity date of April 8, 2025 in the principal sum of $6,210,000. On April 8, 2024, Streeterville paid the purchase price of $5,500,000 in exchange for the Note. On April 10, 2024, the Company repaid in full the remaining outstanding balances for both the Mast Hill $3,500,000 note and the FirstFire $277,777 note, each dated in September 2023.

Robert Mattacchione, the Company’s CEO and Board Chairman, stated, “While the Company continues to work toward closing the previously disclosed RC Consulting Consortium Group LLC transaction, the Ophir gem collection transaction, and monetization of a one-billion dollar gold-backed bond to raise non-dilutive funding, it is very important to have repaid the Mast Hill and FirstFire notes with cash, thereby curtailing dilution.”
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!